Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy

Completed · Phase 1

Conditions studied: Stroke, Transient Ischemic Attack, Myocardial Infarction

In brief

The purpose of this study is to determine the feasibility of pharmacogenomics testing in a community pharmacy using clopidogrel as an example. The investigators hypothesize that this testing is feasible in this setting.

Key facts

Study ID

NCT01495845

Run by

University of North Carolina, Chapel Hill

People needed

48

Starts

2011-12-01

Expected to finish

2012-06-01

Last updated by the study team

2012-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prescribed clopidogrel (Plavix) by their prescriber
• Aged 18 or older
• Currently on clopidogrel therapy for one of the following indicated uses: post-ACS, Recent PCI with stenting, History of TIA or stroke

You may not qualify if…

• Are unable to complete study materials (surveys) with or without assistance, including non-English speaking patients
• Are taking clopidogrel for a reason other than stated in inclusion criteria
• Are pregnant or nursing
• Have an allergy to aspirin

Where it is running

• Kerr Drug — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.